title: Sideroblastic anemia due to linezolid in a patient with a left ventricular assist device.
authors.affiliation: Rush Presbyterian St. Luke's Medical Center, Chicago, Illinois, USA.
authors.forename: Michelle C
authors.initials: MC
authors.lastname: Montpetit
authors.forename: Jamile L
authors.initials: JL
authors.lastname: Shammo
authors.forename: Jerome
authors.initials: J
authors.lastname: Loew
authors.forename: Stephanie
authors.initials: S
authors.lastname: Dunlap
authors.forename: Salpy V
authors.initials: SV
authors.lastname: Pamboukian
authors.forename: Alain
authors.initials: A
authors.lastname: Heroux
mesh_terms: D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000756:Anemia, Sideroblastic / Q000139:chemically induced*; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016027:Heart Transplantation; D006353:Heart-Assist Devices; D006801:Humans; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D016459:Prosthesis-Related Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013212:Staphylococcus epidermidis; D014850:Waiting Lists
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid